Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 710123, 12 pages
http://dx.doi.org/10.1155/2015/710123
Research Article

Inflammatory and Antioxidant Pattern Unbalance in “Clopidogrel-Resistant” Patients during Acute Coronary Syndrome

1National Research Council, Institute of Clinical Physiology, Cardiothoracic and Vascular Department, Niguarda Ca’ Granda Hospital, Piazza Ospedale Maggiore 3, 20162 Milan, Italy
2National Research Council, Institute of Clinical Physiology, Via Moruzzi 1, 56124 Pisa, Italy
3Department of Invasive Cardiology 1, Careggi Hospital, University of Florence, Largo Brambilla 3, 50134 Florence, Italy
4Department of Invasive Cardiology 1, Careggi Hospital, Largo Brambilla 3, 50134 Florence, Italy
5IRCCS, Fondazione Don Gnocchi, Via di Scandicci 269, 50143 Firenze, Italy
6Department of Clinical and Experimental Medicine, University of Pisa, Via Roma 5, 56100 Pisa, Italy

Received 20 November 2014; Revised 30 January 2015; Accepted 2 March 2015

Academic Editor: Dianne Cooper

Copyright © 2015 Raffaele Caruso et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Abbate, G. Cioni, I. Ricci, M. Miranda, and A. M. Gori, “Thrombosis and acute coronary syndrome,” Thrombosis Research, vol. 129, no. 3, pp. 235–240, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Braunwald, D. Angiolillo, E. Bates et al., “Antiplatelet strategies: evaluating their current role in the setting of acute coronary syndromes,” Clinical Cardiology, vol. 31, no. 3, pp. I2–I9, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Braunwald, D. Angiolillo, E. Bates et al., “Clinical considerations with the use of antiplatelet therapy in patients undergoing percutaneous coronary intervention,” Clinical Cardiology, vol. 31, no. 3, pp. I28–I35, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Sofi, R. Marcucci, A. M. Gori, B. Giusti, R. Abbate, and G. F. Gensini, “Clopidogrel non-responsiveness and risk of cardiovascular morbidity: an updated meta-analysis,” Thrombosis and Haemostasis, vol. 103, no. 4, pp. 841–848, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Bonello, U. S. Tantry, R. Marcucci et al., “Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate,” Journal of the American College of Cardiology, vol. 56, no. 12, pp. 919–933, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Parodi, R. Marcucci, R. Valenti et al., “High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI,” Journal of the American Medical Association, vol. 306, no. 11, pp. 1215–1223, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. P. A. Gurbel and U. S. Tantry, “Clopidogrel resistance?” Thrombosis Research, vol. 120, no. 3, pp. 311–321, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Śpiewak, Ł. A. Małek, G. Kostrzewa et al., “Influence of C3435T multidrug resistance gene-1 (MDR-1) polymorphism on platelet reactivity and prognosis in patients with acute coronary syndromes,” Kardiologia Polska, vol. 67, no. 8, pp. 827–834, 2009. View at Google Scholar · View at Scopus
  9. S. Margetic, “Inflammation and haemostasis,” Biochemia Medica, vol. 22, no. 1, pp. 49–62, 2012. View at Google Scholar · View at Scopus
  10. P. Osmancik, P. Paulu, P. Tousek, V. Kocka, and P. Widimsky, “High leukocyte count and interleukin-10 predict high on-treatment-platelet- reactivity in patients treated with clopidogrel,” Journal of Thrombosis and Thrombolysis, vol. 33, no. 4, pp. 349–354, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. A. M. Gori, F. Cesari, R. Marcucci et al., “The balance between pro- and anti-inflammatory cytokines is associated with platelet aggregability in acute coronary syndrome patients,” Atherosclerosis, vol. 202, no. 1, pp. 255–262, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Violi and P. Pignatelli, “Platelet oxidative stress and thrombosis,” Thrombosis Research, vol. 129, no. 3, pp. 378–381, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. D. W. Essex, “Redox control of platelet function,” Antioxidants and Redox Signaling, vol. 11, no. 5, pp. 1191–1225, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Campolo, S. Penco, E. Bianchi et al., “Glutamate-cysteine ligase polymorphism, hypertension, and male sex are associated with cardiovascular events. Biochemical and genetic characterization of Italian subpopulation,” The American Heart Journal, vol. 154, no. 6, pp. 1123–1129, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Malinowska and B. Olas, “Analysis of biological properties of selected elements of haemostasis after treatment with the oxidized form of homocysteine in vitro,” Platelets, vol. 22, no. 8, pp. 629–632, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. M. G. Signorello, A. Segantin, M. Passalacqua, and G. Leoncini, “Homocysteine decreases platelet NO level via protein kinase C activation,” Nitric Oxide: Biology and Chemistry, vol. 20, no. 2, pp. 104–113, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. A. J. López-Farré, P. J. Mateos-Cáceres, D. Sacristán et al., “Relationship between vitamin D binding protein and aspirin resistance in coronary ischemic patients: a proteomic study,” Journal of Proteome Research, vol. 6, no. 7, pp. 2481–2487, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Volpi, L. Giusti, F. Ciregia et al., “Platelet proteome and clopidogrel response in patients with stable angina undergoing percutaneous coronary intervention,” Clinical Biochemistry, vol. 45, no. 10-11, pp. 758–765, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Paniccia, E. Antonucci, N. Maggini et al., “Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients,” Thrombosis and Haemostasis, vol. 104, no. 2, pp. 287–292, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Buonamici, R. Marcucci, A. Migliorini et al., “Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis,” Journal of the American College of Cardiology, vol. 49, no. 24, pp. 2312–2317, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. I. Fricke, D. Mitchell, F. Petersen, A. Böhle, S. Bulfone-Paus, and S. Brandau, “Platelet factor 4 in conjunction with IL-4 directs differentiation of human monocytes into specialized antigen-presenting cells,” The FASEB Journal, vol. 18, no. 13, pp. 1588–1590, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. C. M. Weyand, J. J. Goronzy, G. Liuzzo, S. L. Kopecky, D. R. Holmes Jr., and R. L. Frye, “T-cell immunity in acute coronary syndromes,” Mayo Clinic Proceedings, vol. 76, no. 10, pp. 1011–1020, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. K. L. Jones, J. J. Maguire, and A. P. Davenport, “Chemokine receptor CCR5: from AIDS to atherosclerosis,” British Journal of Pharmacology, vol. 162, no. 7, pp. 1453–1469, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Lacotte, S. Brun, S. Muller, and H. Dumortier, “CXCR3, inflammation, and autoimmune diseases,” Annals of the New York Academy of Sciences, vol. 1173, pp. 310–317, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Olas and B. Wachowicz, “Role of reactive nitrogen species in blood platelet functions,” Platelets, vol. 18, no. 8, pp. 555–565, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Krötz, H.-Y. Sohn, and U. Pohl, “Reactive oxygen species: players in the platelet game,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 11, pp. 1988–1996, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. K. R. Gibson, T. J. Winterburn, F. Barrett, S. Sharma, S. M. MacRury, and I. L. Megson, “Therapeutic potential of N-acetylcysteine as an antiplatelet agent in patients with type-2 diabetes,” Cardiovascular Diabetology, vol. 10, article 43, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Becatti, C. Fiorillo, A. M. Gori et al., “Platelet and leukocyte ROS production and lipoperoxidation are associated with high platelet reactivity in Non-ST elevation myocardial infarction (NSTEMI) patients on dual antiplatelet treatment,” Atherosclerosis, vol. 231, no. 2, pp. 392–400, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Kojima, H. Kanada, S. Shimizu et al., “CD226 mediates platelet and megakaryocytic cell adhesion to vascular endothelial cells,” Journal of Biological Chemistry, vol. 278, no. 38, pp. 36748–36753, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. D. del Principe, G. Frega, I. Savini, M. V. Catani, A. Rossi, and L. Avigliano, “The plasma membrane redox system in human platelet functions and platelet-leukocyte interactions,” Thrombosis and Haemostasis, vol. 101, no. 2, pp. 284–289, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. I. M. Cojocaru, M. Cojocaru, V. Sapira, and A. Ionescu, “Evaluation of oxidative stress in patients with acute ischemic stroke,” Romanian Journal of Internal Medicine, vol. 51, no. 2, pp. 97–106, 2013. View at Google Scholar · View at Scopus
  32. D. L. Steen, C. P. Cannon, S. S. Lele et al., “Prognostic evaluation of catalytic iron in patients with acute coronary syndromes,” Clinical Cardiology, vol. 36, no. 3, pp. 139–145, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Prakash, “Role of non-transferrin-bound iron in chronic renal failure and other disease conditions,” Indian Journal of Nephrology, vol. 17, no. 4, pp. 188–193, 2007. View at Publisher · View at Google Scholar
  34. A. Sener, O. Cevik, G. Yanikkaya-Demirel, S. Apikoglu-Rabus, and D. Ozsavci, “Influence of platelet γ-glutamyltransferase on oxidative stress and apoptosis in the presence of holo-transferrin,” Folia Biologica, vol. 58, no. 5, pp. 193–202, 2012. View at Google Scholar · View at Scopus